Hanne Leth Hillman
Voorzitter bij The Danish Investor Relations Society
Profiel
Hanne Leth Hillman is currently the Co-Chairman at The Danish Investor Relations Society and the Chief Financial Officer at Nanovi Radiotherapy A.
Previously, she held positions such as VP, Director-Investor Relations & Capital Market at NTG Nordic Transport Group A in 2009-2010, Analyst at Gudme Raaschou Bank A in 2004, and Senior VP-Investor Relations & Communications at Zealand Pharma A in 2015-2016.
Ms. Hillman obtained an MBA from the University of Aarhus.
Actieve functies van Hanne Leth Hillman
| Bedrijven | Functie | Begin |
|---|---|---|
| The Danish Investor Relations Society | Voorzitter | - |
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Financieel Directeur/CFO | 01-05-2017 |
Eerdere bekende functies van Hanne Leth Hillman
| Bedrijven | Functie | Einde |
|---|---|---|
| BRAIN+ A/S | Financieel Directeur/CFO | 01-01-2024 |
| ZEALAND PHARMA A/S | Investor Relations Contact | 01-10-2016 |
| Gudme Raaschou Bank A/S | Analyst-Equity | 05-11-2004 |
| NTG NORDIC TRANSPORT GROUP A/S | Investor Relations Contact | - |
Opleiding van Hanne Leth Hillman
| University of Aarhus | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| ZEALAND PHARMA A/S | Health Technology |
| BRAIN+ A/S | Technology Services |
| Bedrijven in privébezit | 3 |
|---|---|
| Gudme Raaschou Bank A/S | Finance |
| The Danish Investor Relations Society | |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
